Search Results 81-90 of 14787 for anti-TNF drugs

1. Anti-Inflammatory Drugs, Nonsteroidal (Ophthalmic Route) Before Using - Mayo Clinic

   Although studies on birth defects have not been done in pregnant women after use of these medicines in the eye, ophthalmic anti-inflammatory medicines have not ...

2. Infliximab-Abda (Intravenous Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Renflexis. Descriptions. Infliximab-abda injection is used ...

3. A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative Colitis - Mayo Clinic

   A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to ...

4. Anti-fibrotic therapy in the treatment of IPF: Ongoing concerns and current practices - Mayo Clinic

   Pirfenidone and nintedanib are approved for treatment of idiopathic pulmonary fibrosis (IPF), but questions remain regarding indications and timing of ...

5. Alzheimer's: Medicines help manage symptoms and slow decline - Mayo Clinic

   FDA-approved medicines for treating symptoms · Goals for treating symptoms · Cholinesterase inhibitors · Memantine · Medicine for agitation · Antiamyloid treatment.

6. Anti-Inflammatory Drugs, Nonsteroidal (Ophthalmic Route) Side Effects - Mayo Clinic

   Check with your doctor as soon as possible if any of the following side effects occur: Less common or rare. Bleeding in the eye or redness or swelling of ...

7. Clinical Trials - Mayo Clinic Research

   ... Anti TNF Therapy. Amended Protocol to Include a Lutikizumab Open-Label Sub-study in Subjects Naïve to Biologic Therapy. A Study to Assess Disease Activity ...

8. Anti-Inflammatory Drugs, Nonsteroidal (Ophthalmic Route) Precautions - Mayo Clinic

   Wearing soft (hydrogel) contact lenses during treatment with diclofenac has caused severe irritation (redness and itching) in some people. Therefore, do not ...

9. AMG 181 in Subjects with Moderate to Severe Crohn's Disease - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name ... A maximum of approximately 80% of subjects with any prior anti-TNF ...

10. Infliximab-Dyyb (Intravenous Route, Subcutaneous Route) Description and Brand Names - Mayo Clinic

    It is also used as a maintenance treatment for moderate to severe active Crohn's disease and ulcerative colitis after receiving an infliximab medicine given by ...